Private company
Societal CDMO, Inc.
Societal CDMO, Inc. is an American pharmaceutical preparations company based in Exton, active since 2007.2
Last updated Oct 21, 2026.
Overview
- IndustryPharmaceutical Preparations2
- HeadquartersExton, United States2
- Incorporated inPA3
- Business address1 E. Uwchlan Ave, Suite 112, Exton, Pa 193413
- Filer categoryNon-accelerated filer, Smaller reporting company3
- Legal formBusiness Corporation2
- LEI2549004EL1Z016VYWA542
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered address1 E. UWCHLAN AVE, 19341 Exton, United States2
- Registered withPennsylvania Department of State, 37691022
See how the biggest companies compare on our leaderboards
On February 28, 2024, we entered into an Agreement and Plan of Merger, or the Merger Agreement, with CoreRx, Inc., or CoreRx, and Cane Merger Sub, Inc., a wholly owned subsidiary of CoreRx, or Merger Sub. Pursuant to the Merger Agreement, and upon the terms and subject to the conditions therein, CoreRx will commence a tender offer, or the Offer, to acquire all of our issued and outstanding shares of common stock, par value $0.01 per share, for approximately $1.10 per share of our common stock, or the Offer Price, in cash, subject to any applicable withholding of taxes and without interest. The Offer will initially expire one minute following 11:59 p.m. (Eastern Time) on the date that is 20 business days following the commencement of the Offer, subject to extension under certain circumstances.5 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023
Where the money goes
Where each dollar of revenue went, fiscal 2023
- Cost of revenue71¢$76.5M
- Selling, general and admin20¢$21.0M
- Interest9¢$10.0M
- Income tax0¢$132.0K
Out of $94.6M in revenue.6 The company lost money this year.
Financial statements
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenue | $71.8M7 | $77.3M8 | $99.2M9 | $66.5M10 | $75.4M6 | $90.2M6 | $94.6M6 |
| Cost of revenue | $38.2M7 | $43.2M8 | $51.0M9 | $54.1M10 | $55.5M6 | $67.1M6 | $76.5M6 |
| Research and development | $4.5M7 | $4.4M8 | |||||
| Selling, general and admin | $14.3M7 | $14.4M8 | $19.9M9 | $18.1M10 | $18.4M6 | $22.0M6 | $21.0M6 |
| Operating expenses | $74.9M6 | $89.9M6 | $98.2M6 | ||||
| Operating income | -$40.3M11 | $12.5M8 | $23.6M9 | -$8.3M10 | $412.0K6 | $279.0K6 | -$3.6M6 |
| Interest | $12.0M7 | $8.1M8 | $19.0M9 | $19.2M10 | $15.1M6 | $14.2M6 | $10.0M6 |
| Income before tax | -$11.4M6 | -$18.8M6 | -$13.1M6 | ||||
| Income tax | $7.3M7 | $17.4M8 | $09 | $010 | $06 | $1.1M6 | $132.0K6 |
| Net income | -$50.1M7 | -$79.7M8 | -$18.6M9 | -$27.5M10 | -$11.4M6 | -$19.9M6 | -$13.3M6 |
| Earnings per share | -$2.637 | -$3.908 | -$0.839 | -$1.1610 | -$0.266 | -$0.346 | -$0.146 |
| Earnings per share (diluted) | -$2.637 | -$3.908 | -$0.799 | -$1.1610 | -$0.266 | -$0.346 | -$0.146 |
| Shares (weighted, basic) | 44.1M shares6 | 57.9M shares6 | 95.2M shares6 | ||||
| Shares (weighted, diluted) | 44.1M shares6 | 57.9M shares6 | 95.2M shares6 |
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Cash | $61.0M11 | $38.5M7 | $19.1M8 | $23.8M9 | $25.2M10 | $15.0M6 | $8.1M6 |
| Receivables | $11.9M10 | $15.9M6 | $16.6M6 | ||||
| Inventory | $8.9M10 | $10.3M6 | $10.3M6 | ||||
| Current assets | $87.3M11 | $71.1M7 | $60.2M8 | $54.1M9 | $57.5M10 | $55.6M6 | $53.5M6 |
| Property, plant and equipment | $51.7M10 | $50.4M6 | $49.8M6 | ||||
| Goodwill | $41.1M10 | $41.1M6 | $41.1M6 | ||||
| Intangible assets | $3.8M10 | $2.9M6 | $2.2M6 | ||||
| Total assets | $186.2M11 | $155.5M7 | $110.5M8 | $103.4M9 | $160.3M10 | $157.4M6 | $153.5M6 |
| Accounts payable | $2.1M10 | $1.5M6 | $1.3M6 | ||||
| Short-term debt | $2.0M10 | $7.6M6 | $36.8M6 | ||||
| Current liabilities | $49.9M11 | $29.0M7 | $6.5M8 | $7.8M9 | $17.7M10 | $22.8M6 | $50.0M6 |
| Long-term debt | $53.6M11 | $64.2M7 | $110.3M8 | $108.1M9 | $95.5M10 | $31.0M6 | $339.0K6 |
| Total liabilities | $157.4M11 | $175.0M7 | $117.2M8 | $117.5M9 | $118.3M10 | $97.6M6 | $94.8M6 |
| Retained earnings | -$245.8M10 | -$265.6M6 | -$278.9M6 | ||||
| Shareholders’ equity | $28.8M8 | -$19.5M9 | -$6.7M10 | -$14.1M6 | $42.1M6 | $59.9M6 | $58.7M6 |
| Shares outstanding | 19.1M shares11 | 21.8M shares7 | 23.3M shares8 | 28.6M shares9 | 46.7M shares10 | 84.6M shares6 | 104.9M shares6 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -$17.0M11 | -$43.1M11 | $10.9M6 | -$3.6M6 | -$1.0M6 | ||
| Stock-based compensation | $6.5M6 | $5.4M6 | $5.0M6 | ||||
| Capital spending | $5.4M7 | $7.2M8 | $8.3M9 | $7.6M10 | $5.3M6 | $8.4M6 | $8.2M6 |
| Free cash flow | -$22.4M | -$50.3M | $5.6M | -$12.0M | -$9.2M | ||
| Cash from investing | -$29.3M6 | -$8.4M6 | -$8.2M6 | ||||
| Cash from financing | $19.9M6 | $1.8M6 | $2.3M6 |
Corporate structure
Societal CDMO, Inc. sits at the top of its group. 4 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Societal CDMO, Inc.
- First Light Asset Management, LLC Filed SC 13D/A on Societal CDMO, Inc., latest Apr 9, 2024 (4 filings since Jan 5, 2023)
- Beryl Capital Management LLC Filed SC 13G on Societal CDMO, Inc., latest Apr 1, 2024
- CORERX INC Filed SC 13D on Societal CDMO, Inc., latest Mar 6, 2024
- AWM Investment Company, Inc. Filed SC 13G/A on Societal CDMO, Inc., latest Feb 14, 2024 (3 filings since Feb 11, 2022)
- Laurence W. Lytton Filed SC 13G/A on Societal CDMO, Inc., latest Feb 14, 2024 (2 filings since Aug 31, 2023)
- Cowen Prime Advisors LLC Filed SC 13G on Societal CDMO, Inc., latest Aug 7, 2023
- Athyrium Funds GP Holdings LLC Filed SC 13G/A on Societal CDMO, Inc., latest Feb 14, 2023
- Samjo Capital LLC Filed SC 13G/A on Societal CDMO, Inc., latest Feb 10, 2023 (2 filings since Feb 8, 2022)
- Railroad Ranch Capital Management, LP Filed SC 13D/A on Societal CDMO, Inc., latest Dec 16, 2022 (3 filings since Jun 27, 2022)
- Gerald Joseph Yakatan & Una Yakatan Family Trust dated April 4, 1989 as amended & fully restated on May 3, 2017 Filed SC 13G on Societal CDMO, Inc., latest Mar 24, 2022
- Portolan Capital Management, LLC Filed SC 13G/A on Societal CDMO, Inc., latest Feb 11, 2022
- RENAISSANCE TECHNOLOGIES LLC Filed SC 13G/A on Societal CDMO, Inc., latest Feb 11, 2022
- Societal CDMO, Inc. Exton, Pennsylvania, United States
- Societal CDMO Gainesville Development, LLC Subsidiary · Delaware, United States
- Societal CDMO Gainesville, LLC Subsidiary · Massachusetts, United States
- Societal CDMO San Diego, LLC Subsidiary · California, United States
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Societal CDMO, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $102.3M6 Dec 31, 2023 | $94.8M6 Dec 31, 2022 | +7.9% |
| Accumulated depreciation | $52.5M6 Dec 31, 2023 | $44.4M6 Dec 31, 2022 | +18.2% |
| Property and equipment, net | $49.8M6 Dec 31, 2023 | $50.4M6 Dec 31, 2022 | −1.1% |
| Operating-lease assets (leased space) | $5.0M6 Dec 31, 2023 | $5.5M6 Dec 31, 2022 | −8.9% |
Investments
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $41.1M6 Dec 31, 2023 | $41.1M6 Dec 31, 2022 | 0% |
| Intangible assets, net (excluding goodwill) | $2.2M6 Dec 31, 2023 | $2.9M6 Dec 31, 2022 | −23.5% |
| Finite-lived intangibles, gross | $19.7M6 Dec 31, 2023 | $19.7M6 Dec 31, 2022 | 0% |
| Accumulated amortization | $17.4M6 Dec 31, 2023 | $16.7M6 Dec 31, 2022 | +4.1% |
| Finite-lived intangibles, net | $2.2M6 Dec 31, 2023 | $2.9M6 Dec 31, 2022 | −23.5% |
Inventory
Leadership
Who has led Societal CDMO, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
- Chief executive officerJ. David Enloe Jr. Dec 18, 2020 to Apr 8, 202414
- Chief executive officerGeraldine Henwood Mar 13, 2014 to Dec 9, 202015
- PresidentGeraldine Henwood Mar 13, 2014 to Dec 9, 202015
- Chief financial officerRyan David Lake Jan 4, 2018 to Apr 8, 202416
- Chief financial officerMichael Celano Jul 5, 2016 to Oct 2, 201717
- Chief operating officerMichael Celano Jan 4, 2018 to Feb 19, 201918
Board members and other officers (22)
- Senior VP, Finance & CAORyan David Lake Jun 7, 2017 to Jun 7, 201719
- Executive VP, Business Dev.Jyrki Mattila Aug 21, 2017 to Jan 4, 201820
- Chief Commercial OfficerFred Graff Feb 18, 2016 to Jan 22, 201821
- Chief Medical OfficerStewart McCallum Dec 2, 2015 to Jan 22, 201822
- Senior VP-Reg./QualityDiane Myers Mar 13, 2014 to Jan 22, 201823
- CAO/ControllerDonna Nichols Mar 13, 2014 to Jan 20, 201724
- Senior VP, DevelopmentRandall Mack Mar 13, 2014 to Jan 22, 201825
- Board memberMathew Paul Arens Aug 25, 2023 to Apr 8, 202426
- Board memberElena Cant Sep 6, 2022 to Apr 8, 202427
- Board memberLaura L. Parks Jun 21, 2021 to Apr 8, 202428
- Board memberJ. David Enloe Jr. Dec 18, 2020 to Apr 8, 202414
- Board memberArnaud Ajdler Mar 27, 2019 to May 11, 202029
- Board memberBryan M. Reasons Mar 6, 2017 to Apr 8, 202430
- Board memberDiane Myers Dec 5, 2016 to Oct 2, 201731
- Board memberKaren Flynn Sep 8, 2015 to Dec 16, 201932
- Board memberAbraham Ludomirski Mar 13, 2014 to Nov 3, 201633
- Board memberAlfred Altomari Mar 13, 2014 to Dec 9, 201934
- Board memberGeraldine Henwood Mar 13, 2014 to May 17, 202115
- Board memberMichael Berelowitz Mar 13, 2014 to May 20, 202235
- Board memberWayne Weisman Mar 13, 2014 to Apr 8, 202436
- Board memberWilliam Ashton Mar 13, 2014 to Apr 8, 202437
- Board memberWinston J. Churchill Mar 13, 2014 to Apr 8, 202438
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- Societal CDMO Gainesville Development, LLC Delaware4
- Societal CDMO Gainesville, LLC Massachusetts4
- Societal CDMO San Diego, LLC California4
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Former names
- Recro Pharma, Inc.Oct 24, 2013 to Mar 21, 20223
Timeline
- Apr 8, 20248-K Ended a material agreement; Completed an acquisition or sale; Listing notice or transfer39
- Mar 15, 20248-K Other events40
- Feb 28, 20248-K Entered a material agreement; Regulation FD disclosure41
- Nov 28, 20238-K Entered a material agreement; Listing notice or transfer42
- Nov 8, 20238-K Results of operations; Regulation FD disclosure43
- Sep 20, 20238-K Exit or restructuring costs; Regulation FD disclosure44
- Aug 28, 20238-K Entered a material agreement45
- Aug 23, 20238-K Executive or director change46
- Aug 14, 20238-K Results of operations; Regulation FD disclosure47
- May 26, 20238-K Listing notice or transfer48
- May 18, 20238-K Shareholder vote49
- May 10, 20238-K Results of operations; Regulation FD disclosure50
- Dec 18, 2020New chief executive J. David Enloe Jr. becomes CEO14
- Mar 13, 2014New chief executive Geraldine Henwood becomes CEO15
- Nov 15, 2007Founded Societal CDMO, Inc. is founded2
Calendar
When it reported results
- Nov 8, 2023Reported quarterly or annual results43
- Aug 14, 2023Reported quarterly or annual results47
- May 10, 2023Reported quarterly or annual results50
- Mar 1, 2023Reported quarterly or annual results51
- Nov 9, 2022Reported quarterly or annual results52
- Aug 10, 2022Reported quarterly or annual results53
- May 11, 2022Reported quarterly or annual results54
- Mar 1, 2022Reported quarterly or annual results55
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
240 filings to the SEC since October 2021: 4 annual reports, 7 quarterly reports, 36 major events, 104 insider forms, 21 large holders, 68 other. The latest 20:
- Apr 18, 202415-12G EDGAR
- Apr 11, 2024EFFECT EDGAR
- Apr 11, 2024EFFECT EDGAR
- Apr 11, 2024EFFECT EDGAR
- Apr 9, 2024SC 13D/A EDGAR
- Apr 8, 2024POS AM EDGAR
- Apr 8, 2024POS AM EDGAR
- Apr 8, 2024POS AM EDGAR
- Apr 8, 2024S-8 POS EDGAR
- Apr 8, 2024S-8 POS EDGAR
- Apr 8, 2024S-8 POS EDGAR
- Apr 8, 2024S-8 POS EDGAR
- Apr 8, 2024S-8 POS EDGAR
- Apr 8, 2024S-8 POS EDGAR
- Apr 8, 2024S-8 POS EDGAR
- Apr 8, 2024S-8 POS EDGAR
- Apr 8, 2024S-8 POS EDGAR
- Apr 8, 2024S-8 POS EDGAR
- Apr 8, 2024S-8 POS EDGAR
- Apr 8, 2024S-8 POS EDGAR
The 240 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
35 open-market trades by officers, directors and large owners since October 2021: 29 buys and 6 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 28, 2023 | Ashton WilliamDirector | Buy | 22,222 | $0.46 | $10.2K | Form 4 |
| Aug 28, 2023 | ENLOE J DAVID JRChief Executive Officer | Buy | 125,000 | $0.40 | $50.0K | Form 4 |
| Aug 28, 2023 | Reasons Bryan M.Director | Buy | 62,500 | $0.40 | $25.0K | Form 4 |
| Aug 28, 2023 | Weisman WayneDirector | Buy | 62,500 | $0.40 | $25.0K | Form 4 |
| Aug 28, 2023 | Miller James CharlesDirector | Buy | 37,500 | $0.40 | $15.0K | Form 4 |
| Aug 28, 2023 | Cant ElenaDirector | Buy | 30,000 | $0.40 | $12.0K | Form 4 |
| Aug 28, 2023 | CHURCHILL WINSTON JDirector | Buy | 62,500 | $0.40 | $25.0K | Form 4 |
| Aug 24, 2023 | AWM Investment Company, Inc.10% owner | Buy | 140,000 | $0.40 | $56.0K | Form 4 |
| Aug 24, 2023 | First Light Asset Management, LLCDirector | Buy | 6,250,000 | $0.40 | $2.5M | Form 4 |
| Apr 27, 2023 | AWM Investment Company, Inc.10% owner | Sale | 370,000 | $0.70 | $259.0K | Form 4 |
| Nov 15, 2022 | ENLOE J DAVID JRChief Executive Officer | Buy | 660 | $1.71 | $1.1K | Form 4 |
| Oct 17, 2022 | ENLOE J DAVID JRChief Executive Officer | Buy | 625 | $1.69 | $1.1K | Form 4 |
| Sep 15, 2022 | ENLOE J DAVID JRChief Executive Officer | Buy | 714 | $1.41 | $1.0K | Form 4 |
| Aug 15, 2022 | ENLOE J DAVID JRChief Executive Officer | Buy | 757 | $1.26 | $954 | Form 4 |
| Jul 15, 2022 | ENLOE J DAVID JRChief Executive Officer | Buy | 1,150 | $0.81 | $932 | Form 4 |
| Jun 15, 2022 | ENLOE J DAVID JRChief Executive Officer | Buy | 1,562 | $0.68 | $1.1K | Form 4 |
| May 16, 2022 | ENLOE J DAVID JRChief Executive Officer | Buy | 1,086 | $0.96 | $1.0K | Form 4 |
| Apr 20, 2022 | AWM Investment Company, Inc.10% owner | Buy | 12,100 | $1.56 | $18.9K | Form 4 |
| Apr 19, 2022 | AWM Investment Company, Inc.10% owner | Buy | 12,100 | $1.56 | $18.9K | Form 4 |
| Apr 18, 2022 | AWM Investment Company, Inc.10% owner | Buy | 15,600 | $1.55 | $24.2K | Form 4 |
All 35 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- First Light Asset Management, LLCSC 13D/A, 4 filings Jan 5, 2023 to Apr 9, 202456
- Beryl Capital Management LLCSC 13G, 1 filing Apr 1, 202457
- CORERX INCSC 13D, 1 filing Mar 6, 202458
- AWM Investment Company, Inc.SC 13G/A, 3 filings Feb 11, 2022 to Feb 14, 202459
- Laurence W. LyttonSC 13G/A, 2 filings Aug 31, 2023 to Feb 14, 202460
- Cowen Prime Advisors LLCSC 13G, 1 filing Aug 7, 202361
- Athyrium Funds GP Holdings LLCSC 13G/A, 1 filing Feb 14, 202362
- Samjo Capital LLCSC 13G/A, 2 filings Feb 8, 2022 to Feb 10, 202363
- Railroad Ranch Capital Management, LPSC 13D/A, 3 filings Jun 27, 2022 to Dec 16, 202264
- Gerald Joseph Yakatan & Una Yakatan Family Trust dated April 4, 1989 as amended & fully restated on May 3, 2017SC 13G, 1 filing Mar 24, 202265
- Portolan Capital Management, LLCSC 13G/A, 1 filing Feb 11, 202266
- RENAISSANCE TECHNOLOGIES LLCSC 13G/A, 1 filing Feb 11, 202267
SEC filer profile
How Societal CDMO, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARSocietal CDMO, Inc.1
- CIK0001588972
- Employer ID (EIN)26-15232331
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Incorporated inPennsylvania1
- Fiscal year endsDecember 311
- Industry code (SIC)2834 Pharmaceutical Preparations1
- SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
- Business address1 E. Uwchlan Ave, Suite 112, Exton, PA 193411
- Phone770-534-82391
- Shares outstanding110,550,922 as of Apr 1, 202468
- Public float$94.3M as of Dec 31, 202368
- On EDGAR sinceOct 24, 20131
- Filings934 in all: 4 (331), 8-K (192), SC 13G/A (38), 4/A (35), 3 (34), 10-Q (30), 424B3 (30), SC 13G (26)1
All 47 form types
CORRESP (21), S-8 (20), S-8 POS (20), 424B5 (15), EFFECT (12), UPLOAD (12), 10-K (10), 8-K/A (9), CT ORDER (9), DEF 14A (9), DEFA14A (9), SC 13D/A (9), S-1/A (8), S-3 (5), SC 13D (5), POS AM (4), 3/A (3), PRE 14A (3), S-1 (3), S-3/A (3), SC 14D9/A (3), SC TO-T/A (3), SC14D9C (3), 424B4 (2), ARS (2), D (2), SC TO-I/A (2), 10-K/A (1), 144 (1), 15-12G (1), 25-NSE (1), 5 (1), 8-A12B (1), CERTNAS (1), FWP (1), S-1MEF (1), SC 14D9 (1), SC TO-I (1), SC TO-T (1)
- Latest filingsAnnual report (10-K) Mar 22, 2024
Quarterly report (10-Q) Nov 8, 2023
Proxy statement (DEF 14A) Apr 6, 2023
Latest 8-K (8-K) Apr 8, 2024
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21SEC EDGARFred Graff, Chief Commercial Officer
- 22
- 23SEC EDGARDiane Myers, Senior VP-Reg./Quality
- 24SEC EDGARDonna Nichols, CAO/Controller
- 25SEC EDGARRandall Mack, Senior VP, Development
- 26SEC EDGARMathew Paul Arens, Board member
- 27SEC EDGARElena Cant, Board member
- 28SEC EDGARLaura L. Parks, Board member
- 29SEC EDGARArnaud Ajdler, Board member
- 30SEC EDGARBryan M. Reasons, Board member
- 31SEC EDGARDiane Myers, Board member
- 32SEC EDGARKaren Flynn, Board member
- 33SEC EDGARAbraham Ludomirski, Board member
- 34SEC EDGARAlfred Altomari, Board member
- 35SEC EDGARMichael Berelowitz, Board member
- 36SEC EDGARWayne Weisman, Board member
- 37SEC EDGARWilliam Ashton, Board member
- 38SEC EDGARWinston J. Churchill, Board member
- 39
- 40SEC EDGAROther events
- 41
- 42
- 43
- 44
- 45SEC EDGAREntered a material agreement
- 46SEC EDGARExecutive or director change
- 47
- 48SEC EDGARListing notice or transfer
- 49SEC EDGARShareholder vote
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68